Search Results

Drug-Eluting Balloons Studied in Infrapopliteal Arteries

August 29, 2011—In the Journal of American College of Cardiology, Andrej Schmidt, MD, et al have published findings from a study that investigated the efficacy of drug-eluting balloons in the treatment of long infrapopliteal lesions with regard to the short-term restenosis rate and midterm clinical result (2011;58:1105–1109).

Invatec Announces Product Milestones at Leipzig Meeting

January 29, 2010—Invatec (Roncadelle, Italy) announced that the first clinical results for the use of the In.Pact Amphirion paclitaxel-eluting balloon for complex critical limb ischemia (CLI) in below-the-knee vessels were presented at the LINC 2010: Leipzig Interventional Course meeting in Leipzig, Germany.

Two-Year ALPS Registry Outcomes Published for LimFlow pDVA System

May 19, 2020—LimFlow SA announced the publication of 2-year data from the ALPS Registry of the LimFlow percutaneous deep vein arterialization (pDVA) system.

Upstream Peripheral’s GoBack Catheter Found to be Effective in Crossing CTOs in Lower Limbs

January 4, 2022—Upstream Peripheral Technologies announced that its GoBack catheter was shown to be effective in crossing difficult peripheral vascular lesions when used to treat patients undergoing complex revascularizations in lower limb arteries.

Spectranetics' PATENT Results Support Laser Atherectomy to Treat Peripheral In-Stent Restenosis

January 24, 2013—Spectranetics Corporation (Colorado Springs, CO) announced final results from the PATENT (Photo-Ablation using the Turbo-Booster and Excimer Laser for In-Stent Restenosis Treatment) study evaluating the safety and efficacy of the Spectranetics peripheral laser atherectomy catheters for the treatment of in-stent restenosis (ISR) in the femoropopliteal artery in the leg.

FDA Approves Intact Vascular's Tack Endovascular System for BTK Dissection Repair

April 14, 2020—Intact Vascular, Inc. announced FDA approval of its Tack (4-F) endovascular system for repair of postangioplasty dissections in the mid/distal popliteal, tibial, and/or peroneal below-the-knee (BTK) arteries ranging in diameter from 1.5 to 4.5 mm.

First BTK Procedures Performed With Stentys Self-Apposing DES

January 28, 2016—Stentys announced the successful completion of the first interventions using the company’s self-apposing, self-expanding drug-eluting stent (DES) to treat below-the-knee (BTK) arterial disease.

ReFlow Medical's Wingman35 and Spex Catheters Receive CE Mark Approval

September 25, 2014—ReFlow Medical, Inc. announced the recent European CE Mark approval and the initial clinical use of the company’s Wingman35 crossing catheter and Spex shapeable support catheter for use in the peripheral vasculature.

Reva Medical Begins Enrollment in the MOTIV IDE Clinical Trial

September 27, 2022—Reva Medical, LLC, announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in the United States and Europe.